Olivier Houille

Title: The Innovative Contributions of Olivier Houille

Introduction

Olivier Houille is a notable inventor based in Magstatt-le-Bas, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have valuable therapeutic properties. With a total of three patents to his name, Houille's work focuses on innovative solutions for various medical conditions.

Latest Patents

One of Houille's latest patents involves the development of Azaindoles for inhibiting aurora2 and other kinases. This invention is directed to physiologically active compounds of general formula (I) and includes compositions containing such compounds, their prodrugs, and pharmaceutically acceptable salts and solvates. These compounds exhibit valuable pharmaceutical properties, particularly their ability to inhibit kinases. Another significant patent provided by Houille includes novel chemical compounds that have tryptase inhibition activity. These compounds are designed for pharmaceutical compositions and methods aimed at treating conditions such as asthma and inflammatory diseases.

Career Highlights

Olivier Houille is currently associated with Aventis Pharmaceuticals Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in advancing the understanding and treatment of various diseases through the development of new compounds.

Collaborations

Throughout his career, Houille has collaborated with esteemed colleagues, including Paul Joseph Cox and Tahir Nadeem Majid. These collaborations have further enhanced the impact of his research and innovations in the field.

Conclusion

Olivier Houille's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through scientific advancements. His patents reflect a deep understanding of complex biological processes and a dedication to developing effective treatments for various medical conditions.